Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDI Guidance Could Heighten Need To Protect DSHEA’s Intent – Harkin

This article was originally published in The Tan Sheet

Executive Summary

Sen. Tom Harkin calls on dietary supplement industry firms to “be vigilant" in protecting their rights under the Dietary Supplement Health and Education Act once FDA publishes the new dietary ingredient notification guidance.
Advertisement

Related Content

Low NDI Notice Compliance Sets Stage For Enforcement – FDA’s Fabricant
In Brief
Dietary Supplement Caucus Goes Bicameral, Adds Hatch, Harkin As Co-Chairs
McCain-Dorgan NDI Guidance, Steroid Provisions In Senate Food Safety Bill
McCain-Dorgan NDI Guidance, Steroid Provisions In Senate Food Safety Bill

Topics

Advertisement
UsernamePublicRestriction

Register

PS105154

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel